A GCSE Biology Case Study on Whether Cannabis Should be reclassified to a Class B Drug

A simple case study on whether marijuana should be reclassified as a Class B drug: In this case study on cannabis, we will explore whether cannabis (now Class C drugs) should be reclassified as Class B drugs. If cannabis is reclassified, drug dealers and employers will discourage drugs and sales as banned. I will also discuss how easy it is for the government to enforce the law on marijuana and how much the public will be hindered.

In 2003, the British Parliament reclassified cannabis from class B drugs and downgraded to reduce the possibility of fines and imprisonment. 302 Although reclassification does not even legalize marijuana or even legalize it, police now have extensive discretion to deal with individual crimes. It is necessary to further exacerbate the justification of arrests, including the use of marijuana in front of young people. However, regarding cannabis trafficking, the maximum penalty for cannabis trafficking increased to 14 years. 303

Last July, Secretary of the Interior David Brenket rekindled the discussion on whether marijuana was legalized. He announced the reclassification of cannabis from category B to category C. This is the lowest class of illegal drugs and is comparable to antidepressants and steroids. The marijuana chronology is thought to date back to the world 's first medical book, or the Chinese pharmacopoeia, Shennong' s Pen Ts'ao, Zend - Avesta in 600 BC, in the year 2737 BC. An excellent "medicinal herb" which is an Indian poem talks about "an addictive resin" of anesthesia. In 1788, following a new Edinburgh pharmacy omitting a special treatment such as "elephant's tooth scraper", "school wall dust wrestling", malaria treatment, "meat insects 7" There were also people who made it. And beans ", marijuana still exists

Cannabis is a UK class B controlled drug. Ownership, production, supply is illegal. "Supply" includes sharing medicine with someone, or giving it (or for free) to friends and relatives. For medical reasons, the law does not permit the use of marijuana as a defense. As early as 2010, the Pharmaceuticals and Medical Regulatory Agency (MHRA) approved Sativex's sputum state (severe rigidity) in patients with multiple sclerosis. However, in 2014 the National Health Service (NICE) recommended medicines available at NHS and Sativex decided not to provide enough benefit to justify the cost.